Haematological Disorders Nutritional, Metabolic, Endocrine Paediatrics
Conditions
Interventions
group 1 by Iron polymaltose complex
group 2 by Liposomal iron
group 3 by Iron Bisglycinate Chelate
group 4 by Micro dispersed iron
group 5 by sun active iron
group 6 by sucrosomial iron
Sponsors
Menoufia faculty of medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age range 6 months till 59 months old no evidence of infection and negative c–reactive protein (CRP) hemoglobin below the WHO stipulated cutoff values to define IDA anemia: hemoglobin <11.0 g/dL, MCV <73 fL and serum ferritin < 12 mg/L. no history of consumption of iron supplements for 4 months ago or history of blood transfusion.
Exclusion criteria
Exclusion criteria: Children who had any signs of infection (fever, vomiting or diarrhea) on blood collection days, children with anemia rather than IDA e.g. hemolytic anemia or haemoglobinopathy (sickle cell disease, beta thalassemia major) children with chronic diseases or drugs that may affect iron absorption
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to compare the efficacy and tolerability of oral iron polymaltose complex, Micro dispersed iron, sun active iron, liposomal iron, sucrosomial iron, and iron bisglycinate chelate in treatment of IDA in preschool children aged 6-59 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare their effect on growth. | — |
Countries
Egypt
Contacts
Public ContactHeba El Zefzaf
lecturer
Outcome results
None listed